Bluejay Diagnostics BJDX
NASDAQ BJDX
$0.95 -0.01 (-1.47%)
At close: Aug 20, 2026 · 10:08 AM UTC

Bluejay Diagnostics (BJDX) Revenue (2022)

Bluejay Diagnostics (BJDX) posted Revenue of $249040.0 for Q2 2022.

Bluejay Diagnostics (BJDX) Revenue (2022) Analysis & Trends

Bluejay Diagnostics has reported Revenue for 1 years, with the latest figure at $249040.0 in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Abbott Laboratories 199.97 Bn 194.36 Bn 7.27 Bn 12.59 Bn
2 Stryker 130.28 Bn 126.81 Bn 4.50 Bn 6.59 Bn
3 Medtronic 120.94 Bn 111.72 Bn 6.41 Bn 9.81 Bn
4 Boston Scientific 75.17 Bn 74.63 Bn 3.85 Bn 5.44 Bn
5 Edwards Lifesciences 52.92 Bn 48.67 Bn 1.35 Bn 1.74 Bn
6 Dexcom 34.68 Bn 32.73 Bn 830.00 Mn 1.31 Bn
7 GE HealthCare Technologies 33.88 Bn 31.77 Bn 2.18 Bn 5.30 Bn
8 Koninklijke Philips 26.45 Bn 23.12 Bn 4.55 Bn 9.61 Bn
9 Steris 23.24 Bn 22.76 Bn 684.20 Mn 1.49 Bn
10 Bluejay Diagnostics 1.97 Mn 1.97 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2022 249,040.00